Third phase trial results of Covaxin to release soon | Master Stroke
Ad



During the press conference, Ella hailed the decision of the Indian drug regulator to approve Covaxin for emergency restricted use and termed it as a giant leap for innovation and novel product development in India. Covaxin, India’s indigenous COVID-19 vaccine by Bharat Biotech, is developed in collaboration with ICMR. 

Ad

LEAVE A REPLY

Please enter your comment!
Please enter your name here